Latest News & Features
Americas
The BPCIA requires a biosimilar applicant to notify the reference product sponsor of its drug no later than 180 days before the first commercial marketing date. Darryl Woo, Erin Ator Thomson, Janice Ta and Wendy Wang of Vinson & Elkins report on some of the pressing issues in this area. 7 April 2016
Americas
In March, Merck unsuccessfully tried to invalidate a patent owned by Bristol-Myers Squibb covering metastatic skin cancer treatment. Ernest Linek of Banner & Witcoff reviews the arguments and the court’s ruling. 7 April 2016
Biotechnology
Law firm Boult Wade Tennant has hired Jason Rutt as an attorney in the firm’s biotechnology and life sciences group in London. 7 April 2016
Americas
Law firm DLA Piper has hired James Czaban as a partner in the firm’s government affairs practice and chair of the firm’s US Food and Drug Administration group in Washington, DC. 7 April 2016
Asia
MRC Technology and the Institut Pasteur of Shanghai, Chinese Academy of Sciences have agreed a partnership that will help develop new therapeutic antibodies. 6 April 2016
Americas
A US man who sold counterfeit erectile dysfunction medications including Viagra online has been jailed for a year and a day. 6 April 2016
Americas
The US Food and Drug Administration has approved a biosimilar version of Janssen Biotech’s drug Remicade. 6 April 2016
Americas
Pharmaceutical company Millennium Pharmaceuticals has sued Actavis, accusing it of infringing a patent covering a drug used to treat myeloma and mantle cell lymphoma. 5 April 2016
Asia
Law firm Foley & Lardner has expanded its intellectual property department and its chemical, biotechnology and pharmaceutical practice by hiring Philippe Riesen as a partner. 5 April 2016
Americas
The Federal Trade Commission has sued Endo Pharmaceuticals for allegedly violating competition laws by agreeing to so-called pay-for-delay settlements surrounding the launch of generic versions of two drugs. 4 April 2016